Challenging oneself intermittently to improve health

Dose-Response

Volumn 12, Issue 4, 2014, Pages 600-618

  Mattson, Mark P ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Brain function; Exercise; Hormesis; Intermittent fasting

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CURCUMIN; EPICATECHIN; NAPHTHAZARIN; PLANT MEDICINAL PRODUCT; PLUMBAGIN; RESVERATROL; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2;

AEROBIC EXERCISE; ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CALORIC RESTRICTION; CELLULAR STRESS RESPONSE; CEREBROVASCULAR ACCIDENT; CHRONIC STRESS; DIET RESTRICTION; ENDURANCE TRAINING; EXERCISE; FOOD DEPRIVATION; FRUITARIAN DIET; HEALTH EDUCATION; HEART INFARCTION; HIV ASSOCIATED DEMENTIA; HORMESIS; HUMAN; INTERMITTENT FASTING; MUSCLE MITOCHONDRION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; RETINA DEGENERATION; RUNNING; SEDENTARY LIFESTYLE; VEGETARIAN DIET;

EID: 84919770341     PISSN: None     EISSN: 15593258     Source Type: Journal    
DOI: 10.2203/dose-response.14-028.Mattson     Document Type: Article

References (130)

1. Ahlskog JE, Geda YE, Graff-Radford NR and Petersen RC. 2011. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc 86:876-884.
2. Ahmed T, Gilani AH, Hosseinmardi N, Semnanian S, Enam SA and Fathollahi Y. 2011. Curcuminoids rescue long-term potentiation impaired by amyloid peptide in rat hippocampal slices. Synapse 65:572-582.
3. Ahmet I, Wan R, Mattson MP, Lakatta EG and Talan M. 2005. Cardioprotection by intermittent fasting in rats. Circulation 112:3115-3121.
4. Alirezaei M, Kemball CC, Flynn CT, Wood MR, Whitton JL and Kiosses WB. 2010. Short-term fasting induces profound neuronal autophagy. Autophagy 6:702-710.
5. Allsopp TE, Kiselev S, Wyatt S and Davies AM. 1995. Role of Bcl-2 in the brain-derived neurotrophic factor survival response. Eur J Neurosci 7:1266-1272.
6. Anson RM, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A, Ingram DK, Lane MA and Mattson MP. 2003. Intermittent fasting dissociates benefcial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci U S A 100:6216-6220.
7. Arumugam TV, Phillips TM, Cheng A, Morrell CH, Mattson MP and Wan R. 2010. Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol 67:41-52.
8. Barker LE, Kirtland KA, Gregg EW, Geiss LS and Thompson TJ. 2011. Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med 40:434-439.
9. Bhardwaj P and Khanna D. 2013. Green tea catechins: defensive role in cardiovascular disorders. Chin J Nat Med 11:345-353.
10. Belkacemi L, Selselet-Attou G, Louchami K, Sener A and Malaisse WJ. 2010. Intermittent fasting modulation of the diabetic syndrome in sand rats. II. In vivo investigations. Int J Mol Med 26:759-765.
11. Berrigan D, Perkins SN, Haines DC and Hursting SD. 2002. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-defcient mice. Carcinogenesis 23:817-822.
12. Bramble DM and Lieberman DE. 2004. Endurance running and the evolution of Homo. Nature 432: 345-352.
13. Calabrese EJ, Mattson MP and Calabrese V. 2010. Resveratrol commonly displays hormesis: occurrence and biomedical signifcance. Hum Exp Toxicol 29:980-1015.
14. Chao CC, Ma YL and Lee EH. 2011. Brain-derived neurotrophic factor enhances Bcl-xL expression through protein kinase casein kinase 2-activated and nuclear factor kappa B-mediated pathway in rat hippocampus. Brain Pathol 21:150-162.
15. Charney DS and Manji HK. 2004. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE. 2004 Mar 16; 2004(225):re5.
16. Chen DY, Bambah-Mukku D, Pollonini G and Alberini CM. 2012. Glucocorticoid receptors recruit the CaMKIIα-BDNF-CREB pathways to mediate memory consolidation. Nat Neurosci 15:1707-1714.
17. Cheng A, Wang S, Cai J, Rao MS and Mattson MP. 2003. Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol 258:319-333.
18. Cheng A, Wan R, Yang JL, Kamimura N, Son TG, Ouyang X, Luo Y, Okun E and Mattson MP. 2012. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines. Nat Commun 3:1250.
19. Choi SY, Son TG, Park HR, Jang YJ, Oh SB, Jin B and Lee J. 2012. Naphthazarin has a protective effect on the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson’s disease model. J Neurosci Res 90:1842-1849.
20. Clarke JD, Hsu A, Yu Z, Dashwood RH and Ho E. 2011. Differential effects of sulforaphane on his-tone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol Nutr Food Res 55:999-1009.
21. Copple IM, Goldring CE, Kitteringham NR and Park BK. 2010. The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity. Handb Exp Pharmacol 196:233-266.
22. Diaz F and Moraes CT. 2008. Mitochondrial biogenesis and turnover. Cell Calcium 44: 24-35.
23. Duan W and Mattson MP. 1999. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson’s disease. J Neurosci Res 57:195-206.
24. Duan W, Guo Z, Jiang H, Ware M, Li XJ and Mattson MP. 2003. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci USA 100:2911-2916.
25. Ellam S and Williamson G. 2013. Cocoa and human health. Annu Rev Nutr. 33:105-128.
26. Everson-Rose SA and Lewis TT. 2005. Psychosocial factors and cardiovascular diseases. Annu Rev Public Health 26:469-500.
27. Fields S. 2004. The fat of the land: do agricultural subsidies foster poor health? Environ Health Perspect 112:A820-823.
28. Fleshner M. 2005; Physical activity and stress resistance: sympathetic nervous system adaptations prevent stress-induced immunosuppression. Exerc Sport Sci Rev. 33:120-126.
29. Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J and Tercé F. 2000. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apop-tosis in HT29 human colon cancer cells. Cancer Res 60:1426-1433.
30. Gavaldà N, Gutierrez H and Davies AM. 2009. Developmental switch in NF-kappaB signalling required for neurite growth. Development 136:3405-3412.
31. Gervois P and Mansouri RM. 2012. PPARα as a therapeutic target in infammation-associated diseases. Expert Opin Ther Targets 16:1113-1125.
32. Gomez-Pinilla F and Hillman C. 2013. The infuence of exercise on cognitive abilities. Compr Physiol 3:403-428.
33. Goodrick CL, Ingram DK, Reynolds MA, Freeman JR and Cider NL. 1983. Differential effects of intermittent feeding and voluntary exercise on body weight and lifespan in adult rats. J Gerontol 38:36-45.
34. Grant RW, Mariani RA, Vieira VJ, Fleshner M, Smith TP, Keylock KT, Lowder TW, McAuley E, Hu L, Chapman-Novakofski K and Woods JA. 2008. Cardiovascular exercise intervention improves the primary antibody response to keyhole limpet hemocyanin (KLH) in previously sedentary older adults. Brain Behav Immun 22:923-932.
35. Greenwood BN, Foley TE, Day HE, Campisi J, Hammack SH, Campeau S, Maier SF and Fleshner M. 2003. Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J Neurosci 23:2889-2898.
36. Greenwood BN and Fleshner M. 2008. Exercise, learned helplessness, and the stress-resistant brain. Neuromolecular Med 10:81-98.
37. Greenwood BN, Loughridge AB, Sadaoui N, Christianson JP and Fleshner M. 2012. The protective effects of voluntary exercise against the behavioral consequences of uncontrollable stress persist despite an increase in anxiety following forced cessation of exercise. Behav Brain Res 233:314-321.
38. Gupta SC, Patchva S and Aggarwal BB. 2013. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15:195-218.
39. Haaland DA, Sabljic TF, Baribeau DA, Mukovozov IM and Hart LE. 2008. Is regular exercise a friend or foe of the aging immune system? A systematic review. Clin J Sport Med 18:539-548.
40. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM and Mattson MP. 2007. Intermittent fasting and caloric restriction ameliorate age-related behavioral defcits in the tri-ple-transgenic mouse model of Alzheimer’s disease. Neurobiol Dis 26:212-220.
41. Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, Cuzick J, Jebb SA, Martin B, Cutler RG, Son TG, Maudsley S, Carlson OD, Egan JM, Flyvbjerg A and Howell A. 2011. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) 35: 714-727.
42. Harvie M, Wright C, Pegington M, McMullan D, Mitchell E, Martin B, Cutler RG, Evans G, Whiteside S, Maudsley S, Camandola S, Wang R, Carlson OD, Egan JM, Mattson MP and Howell A. 2013. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr 110: 1534-1547.
43. Harvie M and Howell T. The 2 Day Diet. 2013; Genesis Breast Cancer Prevention. Random House, Inc., New York, New York. 360 pp.
44. He C, Bassik MC, Moresi V, Sun K, Wei Y, Zou Z, An Z, Loh J, Fisher J, Sun Q, Korsmeyer S, Packer M, May HI, Hill JA, Virgin HW, Gilpin C, Xiao G, Bassel-Duby R, Scherer PE and Levine B. 2012. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481:511-515.
45. Hooper PL, Hooper PL, Tytell M and Vígh L. 2010. Xenohormesis: health benefts from an eon of plant stress response evolution. Cell Stress Chaperones 15:761-770.
46. Hui X, Lam KS, Vanhoutte PM and Xu A. 2012. Adiponectin and cardiovascular health: an update. Br J Pharmacol 165: 574-590.
47. Intlekofer KA and Cotman CW. 2013. Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol Dis 57:47-55.
48. Jamart C, Naslain D, Gilson H and Francaux M. 2013. Higher activation of autophagy in skeletal muscle of mice during endurance exercise in the fasted state. Am J Physiol Endocrinol Metab 305:E964-974.
49. Jang S, Jeong HS, Park JS, Kim YS, Jin CY, Seol MB, Kim BC and Lee MC. 2010. Neuroprotective effects of (-)-epigallocatechin-3-gallate against quinolinic acid-induced excitotoxicity via PI3K pathway and NO inhibition. Brain Res 1313:25-33.
50. Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD, Pearson M, Nassar M, Telljohann R, Maudsley S, Carlson O, John S, Laub DR and Mattson MP. 2007. Alternate day calorie restriction improves clinical fndings and reduces markers of oxidative stress and infammation in overweight adults with moderate asthma. Free Radic Biol Med 42: 665-674.
51. Joshi G and Johnson JA. 2012. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat CNS Drug Discov 7:218-229.
52. Juge N, Mithen RF and Traka M. 2007. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64:1105-1127.
53. Kang G, Kong PJ, Yuh YJ, Lim SY, Yim SV, Chun W and Kim SS. 2004. Curcumin suppresses lipopoly-saccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. J Pharmacol Sci. 94:325-328.
54. Kashiwaya Y, Bergman C, Lee JH, Wan R, King MT, Mughal MR, Okun E, Clarke K, Mattson MP and Veech RL. 2013. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer’s disease. Neurobiol Aging 34:1530-1539.
55. Kawamoto EM, Scavone C, Mattson MP and Camandola S. 2013. Curcumin requires tumor necrosis factor α signaling to alleviate cognitive impairment elicited by lipopolysaccharide. Neurosignals 21:75-88.
56. Kensler TW, Egner PA, Agyeman AS, Visvanathan K, Groopman JD, Chen JG, Chen TY, Fahey JW and Talalay P. 2013. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem 329:163-177.
57. Koul O. 2005. Insect Antifeedants, CRC Press, New York, NY. 1005 pp.
58. Kuipers SD and Bramham CR. 2006. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel 9:580-586.
59. Lee S and Notterpek L. 2013. Dietary restriction supports peripheral nerve health by enhancing endogenous protein quality control mechanisms. Exp Gerontol 48:1085-1090.
60. Lee J, Duan W and Mattson MP. 2002. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82:1367-1375.
61. Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, Pistoia V, Wei M, Hwang S, Merlino A, Emionite L, de Cabo R and Longo VD. 2012. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med 4(124):124ra27.
62. Liao Y, Greenlund KJ, Croft JB, Keenan NL and Giles WH. 2009. Factors explaining excess stroke prevalence in the US Stroke Belt. Stroke 40:3336-3341.
63. Lin CL, Chen TF, Chiu MJ, Way TD and Lin JK. 2009. Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation. Neurobiol Aging 30:81-92.
64. Little JP, Safdar A, Benton CR and Wright DC. 2011. Skeletal muscle and beyond: the role of exercise as a mediator of systemic mitochondrial biogenesis. Appl Physiol Nutr Metab 36: 598-607.
65. Liu Z, Yu Y, Li X, Ross CA and Smith WW. 2011. Curcumin protects against A53T alpha-synuclein-in-duced toxicity in a PC12 inducible cell model for Parkinsonism. Pharmacol Res 63:439-444.
66. Longo VD and Mattson MP. 2014. Fasting: molecular mechanisms and clinical applications. Cell Metab 19:181-192.
67. Maalouf M, Rho JM and Mattson MP. 2009. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 59:293-315.
68. Majmundar AJ, Wong WJ and Simon MC. 2010. Hypoxia-inducible factors and the response to hypox-ic stress. Mol Cell 40:294-309.
69. Mandal MN, Patlolla JM, Zheng L, Agbaga MP, Tran JT, Wicker L, Kasus-Jacobi A, Elliott MH, Rao CV and Anderson RE. 2009. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med 46:672-679.
70. Marosi K, Bori Z, Hart N, Sárga L, Koltai E, Radák Z and Nyakas C. 2012. Long-term exercise treatment reduces oxidative stress in the hippocampus of aging rats. Neuroscience 226:21-28.
71. Marosi K and Mattson MP. 2014. BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab 25: 89-98.
72. Martin B, Ji S, Maudsley S and Mattson MP. 2010. “Control” laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci USA 107:6127-6133.
73. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffno S and Sandri M. 2009. Autophagy is required to maintain muscle mass. Cell Metab 10: 507-515.
74. Mattson MP, Lovell MA, Furukawa K and Markesbery WR. 1995. Neurotrophic factors attenuate glu-tamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65:1740-1751.
75. Mattson MP and Cheng A. 2006. Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci 29: 632-639.
76. Mattson MP and Meffert MK. 2006. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 13:852-860.
77. Mattson MP. 2008. Dietary factors, hormesis and health. Ageing Res Rev 7:43-48.
78. Mattson MP. 2012a. Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab 16: 706-722.
79. Mattson MP. 2012b. Evolutionary aspects of human exercise—born to run purposefully. Ageing Res Rev 11: 347-352.
80. McNally MA and Hartman AL. 2012. Ketone bodies in epilepsy. J Neurochem 121:28-35.
81. Moore RJ, Jackson KG and Minihane AM. 2009. Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr. 102:1790-1802.
82. Moraska A and Fleshner M. 2001. Voluntary physical activity prevents stress-induced behavioral depression and anti-KLH antibody suppression. Am J Physiol Regul Integr Comp Physiol 281:R484-489.
83. Morroni F, Tarozzi A, Sita G, Bolondi C, Zolezzi Moraga JM, Cantelli-Forti G and Hrelia P. 2013. Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson’s disease. Neurotoxicology 36:63-71.
84. Mosley M and Spencer M. 2013. The Fast Diet. Atria Books, New York, New York. 208 pp.
85. Motl RW and Pilutti LA. 2012. The benefts of exercise training in multiple sclerosis. Nat Rev Neurol 8: 487-497.
86. Nath S, Bachani M, Harshavardhana D and Steiner JP. 2012. Catechins protect neurons against mito-chondrial toxins and HIV proteins via activation of the BDNF pathway. J Neurovirol 18:445-455.
87. Nehlig A. 2013. The neuroprotective effects of cocoa favanol and its infuence on cognitive performance. Br J Clin Pharmacol 75:716-727.
88. Newman JC and Verdin E. 2014. Ketone bodies as signaling metabolites. Trends Endocrinol Metab 25: 42-52.
89. Nieman DC, Buckley KS, Henson DA, Warren BJ, Suttles J, Ahle JC, Simandle S, Fagoaga OR and Nehlsen-Cannarella SL. 1995. Immune function in marathon runners versus sedentary controls. Med Sci Sports Exerc 27:986-992.
90. Nieman DC, Dumke CI, Henson DA, McAnulty SR, McAnulty LS, Lind RH and Morrow JD. 2003. Immune and oxidative changes during and following the Western States Endurance Run. Int J Sports Med 24:541-547.
91. Ong SG and Hausenloy DJ. 2012. Hypoxia-inducible factor as a therapeutic target for cardioprotec-tion. Pharmacol Ther 136:69-81.
92. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V and Chung JH. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148:421-433.
93. Piao CS, Gao S, Lee GH, Kim do S, Park BH, Chae SW, Chae HJ and Kim SH. 2010. Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels. Pharmacol Res 61:342-348.
94. Radak Z, Chung HY, Koltai E, Taylor AW and Goto S. 2008. Exercise, oxidative stress and hormesis. Ageing Res Rev 7:34-42.
95. Reuter S, Eifes S, Dicato M, Aggarwal BB and Diederich M. 2008. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76:1340-1351.
96. Rowe GC, Safdar A and Arany Z. 2014. Running forward: new frontiers in endurance exercise biology. Circulation 129: 798-810.
97. Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, Cohen P and Longo VD. 2009. Fasting and cancer treatment in humans: A case series report. Aging (Albany NY) 1: 988-1007.
98. Schroeder EK, Kelsey NA, Doyle J, Breed E, Bouchard RJ, Loucks FA, Harbison RA and Linseman DA. 2009. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid Redox Signal 11:469-480.
99. Shapiro TA, Fahey JW, Dinkova-Kostova AT, Holtzclaw WD, Stephenson KK, Wade KL, Ye L and Talalay P. 2006. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothio-cyanates: a clinical phase I study. Nutr Cancer 55:53-62.
100. Sen R. 2006. Control of B lymphocyte apoptosis by the transcription factor NF-kappaB. Immunity 25:871-883.
101. Sinclair U. 1911. The Fasting Cure. Mitchell Kennerley, New York. 153 pp.
102. Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, Lee YJ, Xiao H and Herman-Antosiewicz A. 2005. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 280:19911-19924.
103. Smith TP, Kennedy SL and Fleshner M. 2004. Infuence of age and physical activity on the primary in vivo antibody and T cell-mediated responses in men. J Appl Physiol 97:491-498.
104. Son TG, Camandola S, Arumugam TV, Cutler RG, Telljohann RS, Mughal MR, Moore TA, Luo W, Yu QS, Johnson DA, Johnson JA, Greig NH and Mattson MP. 2010. Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia. J Neurochem 112:1316-1326.
105. Speaker KJ, Cox SS, Paton MM, Serebrakian A, Maslanik T, Greenwood BN and Fleshner M. 2013. Six weeks of voluntary wheel running modulates infammatory protein (MCP-1, IL-6, and IL-10) and DAMP (Hsp72) responses to acute stress in white adipose tissue of lean rats. Brain Behav Immun 2013 Nov 15. pii: S0889-1591(13)00527-8.
106. Stranahan AM and Mattson MP. 2012. Recruiting adaptive cellular stress responses for successful brain ageing. Nat Rev Neurosci 13: 209-216.
107. Stranahan AM, Lee K, Becker KG, Zhang Y, Maudsley S, Martin B, Cutler RG and Mattson MP. 2010. Hippocampal gene expression patterns underlying the enhancement of memory by running in aged mice. Neurobiol Aging 31:1937-1949.
108. Sun AY, Wang Q, Simonyi A and Sun GY. 2010. Resveratrol as a therapeutic agent for neurodegener-ative diseases. Mol Neurobiol 41:375-383.
109. Sutherland BA, Rahman RM and Appleton I. 2006. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J Nutr Biochem 17:291-306.
110. Tierney M, Fraser A and Kennedy N. 2012. Physical activity in rheumatoid arthritis: a systematic review. J Phys Act Health 9: 1036-1048.
111. Turan B, Tuncay E and Vassort G. 2012. Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. J Bioenerg Biomembr 44:281-296.
112. US Burden of Disease Collaborators. 2013. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 310:591-608.
113. Vincent GK and Velkoff VA. 2010. The next four decades: the older population in the United States 2010 to 2050. U. S. Census Bureau. P25: 1138.
114. Varady KA, Bhutani S, Church EC and Klempel MC. 2009. Short-term modifed alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr 90:1138-1143.
115. Vivar C, Potter MC and van Praag H. 2013. All about running: synaptic plasticity, growth factors and adult hippocampal neurogenesis. Curr Top Behav Neurosci. 15:189-210.
116. Voss MW, Vivar C, Kramer AF and van Praag H. 2013. Bridging animal and human models of exercise-induced brain plasticity. Trends Cogn Sci. 17: 525-544.
117. Wan R, Camandola S and Mattson MP. 2003. Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats. J Nutr 133: 1921-1929.
118. Wan R, Ahmet I, Brown M, Cheng A, Kamimura N, Talan M and Mattson MP. 2010. Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats. J Nutr Biochem 21: 413-417.
119. Wenz T. 2013. Regulation of mitochondrial biogenesis and PGC-1α under cellular stress. Mitochondrion 13: 134-142.
120. Witkin JM and Li X. 2013. Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical effcacy. CNS Neurol Disord Drug Targets 12:487-497.
121. Wu TY, Khor TO, Lee JH, Cheung KL, Shu L, Chen C and Kong AN. 2013. Pharmacogenetics, phar-macogenomics and epigenetics of Nrf2-regulated xenobiotic-metabolizing enzymes and transporters by dietary phytochemical and cancer chemoprevention. Curr Drug Metab 14:688-694.
122. Yang JL, Lin YT, Chuang PC, Bohr VA and Mattson MP. 2014. BDNF and exercise enhance neuronal DNA repair by stimulating CREB-mediated production of apurinic/apyrimidinic endonuclease 1. Neuromolecular Med 16:161-174.
123. Yessoufou A and Wahli W. 2010. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly 2010 Sep 15;140:w13071.
124. Yu ZF and Mattson MP. 1999. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J Neurosci Res 57: 830-839.
125. Zeng H, Trujillo ON, Moyer MP and Botnen JH. 2011. Prolonged sulforaphane treatment activates survival signaling in nontumorigenic NCM460 colon cells but apoptotic signaling in tumorigenic HCT116 colon cells. Nutr Cancer 63:248-255.
126. Zhang C, Browne A, Child D and Tanzi RE. 2010. Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. J Biol Chem 285:28472-28480.
127. Zhao J, Kobori N, Aronowski J and Dash PK. 2006. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett. 393:108-112.
128. Zimmer C. 2004. Human evolution. Faster than a hyena? Running may make humans special. Science 306: 1283.
129. Zuccato C and Cattaneo E. 2009. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311-322.
130. Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, Mukherjee P and Seyfried TN. 2010. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report. Nutr Metab (Lond) 7: 33.